New product launches, presence at trade fairs and congresses, scientific publications, strategic alliances, corporate developments... You’ll find all our news in this section. Don’t hesitate to get in touch with us if you require any further information.
The operation involves the acquisition of the portfolios of medical prescription and consumer healthcare products, the incorporation of specialized human resources and an agreement whereby Bioiberica will continue producing and supplying APIs and ingredients to Reig Jofre
Spain has approved the use of Cera Trap by non-professionals, as well as its use on minor crops such as fig and pomegranate
Cera Trap is a liquid food attractant, highly efficient and pesticide-free, specifically designed for the management of ceratitis capitata, the Mediterranean fruit fly
The company is leader in the production of heparin API and a global reference in the research, production and marketing of other active pharmaceutical ingredients and compounds of animal origin such as chondroitin sulfate, glucosamine, hyaluronic acid, type II native collagen, or tyroid
Bioiberica will present two posters with novel data on the influence of various osteoarthritis drugs on the risk of virtual joint replacrement and systemic inflammation associated with this condition
Our company will have their own booth at the exhibitors’ area, where they will present their portfolio of prescription products and dietary supplements for joint healthcare.